DePuy Synthes vs. NuVasive vs. Globus Medical: 7 key comparisons

Spinal Tech

NuVasive, Globus Medical and DePuy Synthes, part of Johnson & Johnson, are three leaders in the orthopedic and spine device space.

Here's how the device companies compare in three areas:

1. Finances

DePuy Synthes: $2.1 billion revenue in Q1 2021

NuVasive: $271.2 million net sales in Q1 2021

Globus Medical: $227.3 million net sales in Q1 2021

2. No. of employees

DePuy Synthes: 12,000
NuVasive: 2,700
Globus Medical: 1,800

3. Executive leadership

DePuy Synthes: Aldo Denti, Company Group Chairman (2018 — present)

NuVasive: Chris Barry, CEO (2018 — present)

Globus Medical: David Demski, CEO (2017 — present)

4. Headquarters

DePuy Synthes: West Chester, Pa.

NuVasive: San Diego

Globus Medical: Audubon, Pa.

5. Year founded

DePuy Synthes: 1895

NuVasive: 1997

Globus Medical: 2003

6. Key spine, orthopedic products

DePuy Synthes: DePuy has an expansive portfolio including the Velys robotic-assisted solution, Attune total knee system and the Bi-Mentum Dual Mobility System.

NuVasive: NuVasive has a wide selection of spinal products including the eXtreme lateral interbody fusion procedure, Magec rods and Precice limb-lengthening system.

Globus Medical: Globus Medical's portfolio comprises a variety of spinal screws, plates, biologics and its flagship ExcelsiusGPS robot.

7. Notable news this year

DePuy Synthes: Velys received FDA clearance for use with the Attune knee system.

NuVasive: NuVasive submitted its Pulse system and associated robotics application for FDA clearance, which are expected to launch this summer.

Globus Medical: Globus Medical launched Creo One, the market's first robotic screw designed for spine surgery with ExcelsiusGPS.

Copyright © 2023 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Podcast

Featured Whitepapers